ArticleThe Journal of clinical investigation2025

Targeting MTAP increases PARP inhibitor susceptibility in triple-negative breast cancer through a feed-forward loop.

Xiangyu Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.